Page last updated: 2024-10-24

verapamil and Leukemia, T-Cell

verapamil has been researched along with Leukemia, T-Cell in 8 studies

Verapamil: A calcium channel blocker that is a class IV anti-arrhythmia agent.
verapamil : A racemate comprising equimolar amounts of dexverapamil and (S)-verapamil. An L-type calcium channel blocker of the phenylalkylamine class, it is used (particularly as the hydrochloride salt) in the treatment of hypertension, angina pectoris and cardiac arrhythmia, and as a preventive medication for migraine.
2-(3,4-dimethoxyphenyl)-5-{[2-(3,4-dimethoxyphenyl)ethyl](methyl)amino}-2-(propan-2-yl)pentanenitrile : A tertiary amino compound that is 3,4-dimethoxyphenylethylamine in which the hydrogens attached to the nitrogen are replaced by a methyl group and a 4-cyano-4-(3,4-dimethoxyphenyl)-5-methylhexyl group.

Leukemia, T-Cell: A malignant disease of the T-LYMPHOCYTES in the bone marrow, thymus, and/or blood.

Research Excerpts

ExcerptRelevanceReference
" This fact permits the use of high Drol Z dosage in order to achieve a relevant modulating effect in vivo and to use this drug in combination with a further modulator so as to reach maximum efficacy with tolerable side effects."1.30In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants. ( Gieseler, F; Gullis, E; Hasmann, M; Löser, R; Nüssler, V; Pelka-Fleisc, R; Stötzer, O; Wilmanns, W; Zwierzina, H, 1998)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's7 (87.50)18.2507
2000's0 (0.00)29.6817
2010's1 (12.50)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tajima, Y1
Nakagawa, H1
Tamura, A1
Kadioglu, O1
Satake, K1
Mitani, Y1
Murase, H1
Regasini, LO1
Bolzani, Vda S1
Ishikawa, T1
Fricker, G1
Efferth, T1
Soudon, J1
Berlion, M1
Lucas, C1
Haddad, P1
Bizzari, JP1
Calvo, F1
Principe, P1
Faussat-Suberville, AM1
Coulomb, H1
Marie, JP1
Braquet, P1
Hill, BT1
Hosking, LK1
Didier, A1
Wenger, J1
Loor, F1
Davey, MW1
Hargrave, RM1
Davey, RA1
Kantharidis, P1
El-Osta, A1
deSilva, M1
Wall, DM1
Hu, XF1
Slater, A1
Nadalin, G1
Parkin, JD1
Zalcberg, JR1
Nüssler, V1
Pelka-Fleisc, R1
Gieseler, F1
Hasmann, M1
Löser, R1
Gullis, E1
Stötzer, O1
Zwierzina, H1
Wilmanns, W1

Trials

1 trial available for verapamil and Leukemia, T-Cell

ArticleYear
In vitro activity of S 9788 on a multidrug-resistant leukemic cell line and on normal hematopoietic cells-reversal of multidrug resistance by sera from phase I-treated patients.
    Cancer chemotherapy and pharmacology, 1995, Volume: 36, Issue:3

    Topics: Antineoplastic Agents; Bone Marrow Cells; Cell Division; Cell Line; Cell Survival; Culture Media; Do

1995

Other Studies

7 other studies available for verapamil and Leukemia, T-Cell

ArticleYear
Nitensidine A, a guanidine alkaloid from Pterogyne nitens, is a novel substrate for human ABC transporter ABCB1.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2014, Feb-15, Volume: 21, Issue:3

    Topics: Adenosine Triphosphatases; Antineoplastic Agents, Phytogenic; ATP Binding Cassette Transporter, Subf

2014
Flow cytometric monitoring of anthracycline accumulation after anti-neoplastic ether phospholipid treatment.
    Anti-cancer drugs, 1994, Volume: 5, Issue:3

    Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporine; Daunor

1994
Differential effectiveness of a range of novel drug-resistance modulators, relative to verapamil, in influencing vinblastine or teniposide cytotoxicity in human lymphoblastoid CCRF-CEM sublines expressing classic or atypical multidrug resistance.
    Cancer chemotherapy and pharmacology, 1994, Volume: 33, Issue:4

    Topics: Cyclosporine; Dihydropyridines; Dose-Response Relationship, Drug; Drug Resistance; Drug Screening As

1994
Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers.
    Anti-cancer drugs, 1995, Volume: 6, Issue:5

    Topics: Animals; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cyclosporin

1995
Comparison of drug accumulation in P-glycoprotein-expressing and MRP-expressing human leukaemia cells.
    Leukemia research, 1996, Volume: 20, Issue:8

    Topics: Antibiotics, Antineoplastic; Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subf

1996
Altered methylation of the human MDR1 promoter is associated with acquired multidrug resistance.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 1997, Volume: 3, Issue:11

    Topics: Antimetabolites, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Azacitidin

1997
In vitro efficacy of known P-glycoprotein modulators compared to droloxifene E and Z: studies on a human T-cell leukemia cell line and their resistant variants.
    Leukemia & lymphoma, 1998, Volume: 31, Issue:5-6

    Topics: Antibodies, Monoclonal; ATP Binding Cassette Transporter, Subfamily B, Member 1; ATP-Binding Cassett

1998